- Home
- EVO vs TILE Comparison
EVO vs TILE Comparison
Compare EVO & TILE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- TILE
- Stock Information
- Founded
- EVO 1993
- TILE 1973
- Country
- EVO Germany
- TILE United States
- Employees
- EVO N/A
- TILE N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- TILE Home Furnishings
- Sector
- EVO Health Care
- TILE Consumer Discretionary
- Exchange
- EVO Nasdaq
- TILE Nasdaq
- Market Cap
- EVO 1.4B
- TILE 1.2B
- IPO Year
- EVO 2021
- TILE N/A
- Fundamental
- Price
- EVO $3.76
- TILE $20.12
- Analyst Decision
- EVO Buy
- TILE Buy
- Analyst Count
- EVO 2
- TILE 1
- Target Price
- EVO $5.90
- TILE $30.00
- AVG Volume (30 Days)
- EVO 159.9K
- TILE 340.3K
- Earning Date
- EVO 08-13-2025
- TILE 08-01-2025
- Dividend Yield
- EVO N/A
- TILE 0.20%
- EPS Growth
- EVO N/A
- TILE 44.62
- EPS
- EVO N/A
- TILE 1.46
- Revenue
- EVO $851,944,444.00
- TILE $1,323,328,000.00
- Revenue This Year
- EVO $10.08
- TILE $5.19
- Revenue Next Year
- EVO $10.99
- TILE $4.91
- P/E Ratio
- EVO N/A
- TILE $13.76
- Revenue Growth
- EVO 1.50
- TILE 5.41
- 52 Week Low
- EVO $2.84
- TILE $14.13
- 52 Week High
- EVO $5.64
- TILE $27.34
- Technical
- Relative Strength Index (RSI)
- EVO 41.37
- TILE 48.46
- Support Level
- EVO $4.06
- TILE $20.01
- Resistance Level
- EVO $4.44
- TILE $21.51
- Average True Range (ATR)
- EVO 0.11
- TILE 0.44
- MACD
- EVO -0.04
- TILE -0.08
- Stochastic Oscillator
- EVO 0.00
- TILE 24.86
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment.